<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-pharmaceutics-12-00688">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Eid</surname>
    <given-names>H.M.</given-names>
   </name>
   <name>
    <surname>Elkomy</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>El Menshawe</surname>
    <given-names>S.F.</given-names>
   </name>
   <name>
    <surname>Salem</surname>
    <given-names>H.F.</given-names>
   </name>
  </person-group>
  <article-title>Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: The Influence of Pegylation and Chitosan Coating</article-title>
  <source>AAPS PharmSciTech</source>
  <year>2019</year>
  <volume>20</volume>
  <fpage>183</fpage>
  <pub-id pub-id-type="doi">10.1208/s12249-019-1371-6</pub-id>
  <?supplied-pmid 31054011?>
  <pub-id pub-id-type="pmid">31054011</pub-id>
 </element-citation>
</ref>
